The U.S. Food and Drug Administration on Monday approved a once-a-day AIDS medicine that combines four drugs in one pill and is produced by Gilead Sciences, Inc.
The drug is designed to treat HIV-1 infection in adults who have never been treated for HIV infection, according to the FDA.
Brand-named Stribild, the pill contains two previously approved HIV drugs plus two new drugs.
“Through continued research and drug development, treatment for those infected with HIV has evolved from multi-pill regimens to single-pill regimens,” Dr. Edward Cox, director of the Office of Antimicrobial Products in FDA’s Center for Drug Evaluation and Research said in a statement. “New combination HIV drugs like Stribild help simplify treatment regimens.” A link to the FDA statement is here.